Skip to main content
Erschienen in: Cancer Causes & Control 10/2014

01.10.2014 | Original paper

Germ cell tumors in children and adolescents in Finland: trends over 1969–2008

verfasst von: Satu-Liisa Pauniaho, Jonna Salonen, Mika Helminen, Oskari Heikinheimo, Kim Vettenranta, Markku Heikinheimo

Erschienen in: Cancer Causes & Control | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Malignant germ cell tumors (GCTs) are a heterogeneous group of neoplasms putatively originating from the primordial germ cell. In adults, an increasing incidence of GCTs, particularly testicular tumors, has been reported in recent decades. However, population-based evidence in children and adolescents remains limited. We investigated the incidence of malignant GCTs diagnosed in childhood or adolescence, using population-based nationwide data from Finland.

Methods

We obtained information from the Finnish Cancer Registry on all malignant GCTs registered in 1969–2008 in children or adolescents aged 0–19 years. Data on tumor location, histology, stage, and survival were collected. Age-standardized incidence and survival rates were calculated.

Results

A total of 334 cases of malignant GCT were identified. Their proportion among all malignant tumors among 0- to 19-year-olds increased from 3 to 9.7 % in boys with time, but remained stable in girls (3 %). The overall incidence rate was 0.6 per 100,000 (0.8 in boys and 0.4 in girls), and differed significantly between the age groups. A significant increase in the incidence of testicular GCTs was seen in boys in the age group of 15–19 years.

Conclusions

Although malignant GCTs are rare, their relative frequency in children and adolescents has increased during recent decades, the change being mainly due to an increasing frequency of the testicular tumors among teenagers. The causes of the increase remain unknown, but environmental exposures are likely to be involved.
Literatur
1.
Zurück zum Zitat Bussey KJ, Lawce HJ, Himoe E et al (2001) SNRPN methylation patterns in germ cell tumors as a reflection of primordial germ cell development. Genes Chromosomes Cancer 32:342–352PubMedCrossRef Bussey KJ, Lawce HJ, Himoe E et al (2001) SNRPN methylation patterns in germ cell tumors as a reflection of primordial germ cell development. Genes Chromosomes Cancer 32:342–352PubMedCrossRef
2.
Zurück zum Zitat Schneider DT, Schuster AE, Fritsch MK et al (2001) Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors. Cancer Res 61:7268–7276PubMed Schneider DT, Schuster AE, Fritsch MK et al (2001) Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors. Cancer Res 61:7268–7276PubMed
3.
Zurück zum Zitat Kroll ME, Murphy MF, Carpenter LM, Stiller CA (2011) Childhood cancer registration in Britain: capture-recapture estimates of completeness of ascertainment. Br J Cancer 104:1227–1233PubMedCentralPubMedCrossRef Kroll ME, Murphy MF, Carpenter LM, Stiller CA (2011) Childhood cancer registration in Britain: capture-recapture estimates of completeness of ascertainment. Br J Cancer 104:1227–1233PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Rossig C, Juergens H, Schrappe M et al (2013) Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria. Pediatr Blood Cancer 60:1574–1581PubMedCrossRef Rossig C, Juergens H, Schrappe M et al (2013) Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria. Pediatr Blood Cancer 60:1574–1581PubMedCrossRef
5.
Zurück zum Zitat Huyghe E, Matsuda T, Thonneau P (2003) Increasing incidence of testicular cancer worldwide: a review. J Urol 170:5–11PubMedCrossRef Huyghe E, Matsuda T, Thonneau P (2003) Increasing incidence of testicular cancer worldwide: a review. J Urol 170:5–11PubMedCrossRef
6.
Zurück zum Zitat Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (2010) International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 19:1151–1159PubMedCentralPubMedCrossRef Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (2010) International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 19:1151–1159PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Pauniaho SL, Salonen J, Helminen M, Vettenranta K, Heikinheimo M, Heikinheimo O (2012) The incidences of malignant gonadal and extragonadal germ cell tumors in males and females: a population-based study covering over 40 years in Finland. Cancer Causes Control 23:1921–1927PubMedCrossRef Pauniaho SL, Salonen J, Helminen M, Vettenranta K, Heikinheimo M, Heikinheimo O (2012) The incidences of malignant gonadal and extragonadal germ cell tumors in males and females: a population-based study covering over 40 years in Finland. Cancer Causes Control 23:1921–1927PubMedCrossRef
8.
Zurück zum Zitat Arora RS, Alston RD, Eden TO, Geraci M, Birch JM (2012) Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003. Cancer 118(17):4280–4287 Arora RS, Alston RD, Eden TO, Geraci M, Birch JM (2012) Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003. Cancer 118(17):4280–4287
9.
Zurück zum Zitat Smith HO, Berwick M, Verschraegen CF et al (2006) Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 107:1075–1085PubMedCrossRef Smith HO, Berwick M, Verschraegen CF et al (2006) Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 107:1075–1085PubMedCrossRef
10.
Zurück zum Zitat Schneider DT, Calaminus G, Koch S et al (2004) Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols. Pediatr Blood Cancer 42:169–175PubMedCrossRef Schneider DT, Calaminus G, Koch S et al (2004) Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols. Pediatr Blood Cancer 42:169–175PubMedCrossRef
11.
Zurück zum Zitat Teppo L, Pukkala E, Lehtonen M (1994) Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 33:365–369PubMedCrossRef Teppo L, Pukkala E, Lehtonen M (1994) Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 33:365–369PubMedCrossRef
13.
Zurück zum Zitat Stiller CA, Desandes E, Danon SE et al (2006) Cancer incidence and survival in European adolescents (1978–1997). Report from the automated childhood cancer information system project. Eur J Cancer 42:2006–2018PubMedCrossRef Stiller CA, Desandes E, Danon SE et al (2006) Cancer incidence and survival in European adolescents (1978–1997). Report from the automated childhood cancer information system project. Eur J Cancer 42:2006–2018PubMedCrossRef
14.
Zurück zum Zitat Ruf CG, Isbarn H, Wagner W, Fisch M, Matthies C, Dieckmann KP (2014) Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing. Urol Oncol 32.e1:33.e3 Ruf CG, Isbarn H, Wagner W, Fisch M, Matthies C, Dieckmann KP (2014) Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing. Urol Oncol 32.e1:33.e3
15.
Zurück zum Zitat Oosterhuis JW, Looijenga LH (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5:210–222PubMedCrossRef Oosterhuis JW, Looijenga LH (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5:210–222PubMedCrossRef
16.
Zurück zum Zitat Jorgensen N, Vierula M, Jacobsen R et al (2011) Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl 34:e37–e48PubMedCentralPubMedCrossRef Jorgensen N, Vierula M, Jacobsen R et al (2011) Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl 34:e37–e48PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Sharpe RM, Skakkebaek NE (2008) Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril 89:e33–e38PubMedCrossRef Sharpe RM, Skakkebaek NE (2008) Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril 89:e33–e38PubMedCrossRef
Metadaten
Titel
Germ cell tumors in children and adolescents in Finland: trends over 1969–2008
verfasst von
Satu-Liisa Pauniaho
Jonna Salonen
Mika Helminen
Oskari Heikinheimo
Kim Vettenranta
Markku Heikinheimo
Publikationsdatum
01.10.2014
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 10/2014
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0439-6

Weitere Artikel der Ausgabe 10/2014

Cancer Causes & Control 10/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.